---
category: news
title: "Kiromic BioPharma Announces Strategic Collaboration with Gemelli Teaching Hospital to Accelerate the Analysis of Allogeneic CAR-T Clinical Trial Candidate Alexis ISO-1 in Solid ..."
excerpt: "Alexis ISO-1 is Companyâ€™s First Artificial Intelligence-identified, Gamma Delta T Cell Engineered Iso-Mesothelin Candidate to Address Solid Tumor Cancers HOUSTON-- ( BUSINESS WIRE )--Kiromic BioPharma,"
publishedDateTime: 2021-10-11T16:02:00Z
originalUrl: "https://www.businesswire.com/news/home/20211011005172/en/Kiromic-BioPharma-Announces-Strategic-Collaboration-with-Gemelli-Teaching-Hospital-to-Accelerate-the-Analysis-of-Allogeneic-CAR-T-Clinical-Trial-Candidate-Alexis-ISO-1-in-Solid-Cancers"
webUrl: "https://www.businesswire.com/news/home/20211011005172/en/Kiromic-BioPharma-Announces-Strategic-Collaboration-with-Gemelli-Teaching-Hospital-to-Accelerate-the-Analysis-of-Allogeneic-CAR-T-Clinical-Trial-Candidate-Alexis-ISO-1-in-Solid-Cancers"
type: article

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI in Healthcare
  - AI

secured: "yAeNiVaUkwZRVOI0N0NsF5+ik67hK6Em6c2VmVXiaVbjcg5z4JR2z1FFharVQwiRfnmLzuTWwPln4BMlu4Y4X+4W1064yxR52vM+5kOFFVDJTNebnEtfw+1T5NV4Dguy9HvSznqYYTugaO8tvZEX6N25VESb0ZcP7Whq5bz5sfgdiq6EdzxL52sqmpQutst/wuS3HteoZFjwfAi1pZjKG/xyNnT5x9QuFPJzZ5ej4EvB0MflNqSFG2BknhPgeRtRUHnEepOiJXQeIJgFckzeH6vTUSf+CDzd1F7Cvv9icjKYS4PMa2vV8jib1hhmoxSvyCrFEmR+zXDCPCz+pTdNZf81fHX8+K9C4zqnvlechmQ=;Y4IFl1+eILo+nPC6gKM90g=="
---

